Nuclear Medicine Newswire

Nuclear Medicine Newswire

Comprehensive Real-Time News Feed for Nuclear Medicine.

Results 1 - 20 of 196 in Nuclear Medicine

  1. Brain scans may change care for some people with memory lossRead the original story w/Photo

    Wednesday Jul 19 | Herald Star Online

    ... For now, in addition to people who qualify for the IDEAS study, the Alzheimer's Association and Society of Nuclear Medicine and Molecular Imaging say: -Unusually young dementia patients, younger than 65, also might be candidates for a PET scan. -The ...

    Comment?

  2. SNMMI technologist section announces 2017 award winnersRead the original story w/Photo

    Wednesday Jul 19 | EurekAlert!

    The Society of Nuclear Medicine and Molecular Imaging's Technologist Section -- an international scientific and medical organization -- recognized contributions to and work in the field of nuclear medicine and molecular imaging during the SNMMI 2017 Annual Meeting in Denver, Colorado, held June 10-14. Several awards ceremonies were held to recognize the valuable role that SNMMI-TS members play in advancing the discipline of nuclear medicine technology.

    Comment?

  3. Brain Scans May Change Care for Some People With Memory LossRead the original story w/Photo

    May 20, 2017 | The Daily News

    ... For now, in addition to people who qualify for the IDEAS study, the Alzheimer's Association and Society of Nuclear Medicine and Molecular Imaging say: The scans shouldn't be used as a screening tool for people without symptoms or who worry they're ...

    Comment?

  4. New tool can detect small stroke-causing clotsRead the original story

    Thursday Jul 6 | Newkerala.com

    ... analysis confirm the preclinical data and were presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in June. "Although the current studies are preliminary, 18F-GP1 may provide not only more accurate ...

    Comment?

  5. Novel small molecule tracer for PET imaging spots small blood clotsRead the original story w/Photo

    Thursday Jul 6 | Medical News

    Blood clots in veins and arteries can lead to heart attack, stroke, and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine 's July 2017 issue, German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet clumping, with a fluorine-18 labeled ligand is a promising approach for diagnostic imaging.

    Comment?

  6. Novel PET tracer detects small blood clotsRead the original story w/Photo

    Thursday Jul 6 | PhysOrg Weblog

    ... and pulmonary embolism, which are major causes of mortality. In the featured article of The Journal of Nuclear Medicine 's (JNM) July 2017 issue, German researchers show that targeting GPIIb/IIIa receptors, the key receptor involved in platelet ...

    Comment?

  7. Siemens Healthineers debut new SPECT/CT systemRead the original story w/Photo

    Thursday Jul 6 | Applied Radiology

    Siemens Healthineers debuted a new SPECT/CT system, the Symbia Intevo Bold, at the 2017 annual meeting of the Society of Nuclear Medicine & Molecular Imaging held this month in Denver. The system combines single-photon emission computed tomography technologies with new, high-performance CT capabilities to enable a wide range of clinical applications.

    Comment?

  8. Panel Convened at Society of Nuclear Medicine and Molecular Imaging...Read the original story w/Photo

    Wednesday Jun 28 | PRWeb

    Piet Louw, NTP Frank de Lange, Curium Sally Schwarz, SNMMI Pres Jayne Senior Jean-Michel Vanderhofstadt, IRE Roy Brown, Curium Supplies of the critical medical isotope molybdenum-99 are secure and reliable according to a panel of leading experts gathered at the Society of Nuclear Medicine and Molecular Imaging 2017 annual meeting in Denver, Colorado in June. Mo-99 is the parent isotope of technetium-99m , which is used in 30 to 40 million nuclear medicine procedures worldwide every year.

    Comment?

  9. A unique amino acid for brain cancer therapyRead the original story w/Photo

    Jun 23, 2017 | PhysOrg Weblog

    ... 10.1039/C7CC03337K Researchers presenting a preclinical study at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrated the efficacy and optimal dose for targeted photodynamic therapy (tPDT) to ... ...

    Comment?

  10. The Journal of Nuclear Medicine impact factor increasesRead the original story w/Photo

    Jun 19, 2017 | EurekAlert!

    The Journal of Nuclear Medicine --the flagship publication of the Society of Nuclear Medicine and Molecular Imaging --has again been ranked among the top medical imaging journals worldwide, according to new data released in the 2016 Journal Citation Reports published by Thomson Reuters. JNM's impact factor went up from 5.849 to 6.646 , and the journal ranked fifth in impact factor of the 125 journals included in the medical imaging category.

    Comment?

  11. SNMMI Image of the Year: PET and optical imaging for prostate cancer diagnosis and therapyRead the original story w/Photo

    Jun 14, 2017 | PhysOrg Weblog

    ... may have a high clinical impact on outcomes. Researchers at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrated preclinically that dual-labeled PSMA-inhibitors based on PSMA-11 enhance preoperative ...

    Comment?

  12. Dual-agent PET/MR with time of flight detects more cancerRead the original story w/Photo

    Jun 14, 2017 | PhysOrg Weblog

    ... metastases at a lower dose, according to research presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). "For certain patients with breast and prostate cancer who require evaluation of metastatic ...

    Comment?

  13. Prostate PET/CT targets more cancer and improves patient careRead the original story w/Photo

    Jun 13, 2017 | EurekAlert!

    ... if their cancer returns, according to research revealed at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). This is the first prospective study to include far-reaching data from four Australian medical ...

    Comment?

  14. Single dual time-point PET scan identifies dual Alzheimer's biomarkersRead the original story w/Photo

    Jun 14, 2017 | PhysOrg Weblog

    ... patients maintain quality of life. A new study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates that a single dual time-point PET scan could identify important biomarkers of ...

    Comment?

  15. Renowned Interventional Radiologist Brings Groundbreaking New Techniques To Saint Francis HealthcareRead the original story

    Jun 14, 2017 | PRWeb

    Saint Francis Healthcare announced the addition of pioneering vascular and interventional radiologist Mark J. Garcia, M.D., F.S.I.R., F.A.C.R to our medical staff at Saint Francis Healthcare. Saint Francis Healthcare announced the addition of pioneering vascular and interventional radiologist Mark J. Garcia, M.D., F.S.I.R., F.A.C.R to our medical staff at Saint Francis Healthcare.

    Comment?

  16. Antibody-based theranostic agent shows promise for identifying and treating pancreatic tumorsRead the original story w/Photo

    Jun 13, 2017 | Medical News

    Pancreatic cancer is associated with bleak five-year survival rates and limited treatment options, but new research is offering hope. A first-in-human study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging demonstrates the feasibility and safety of the novel human monoclonal antibody HuMab-5B1 with highly specific targeting for the cancer antigen 19-9, which is expressed on pancreatic tumors and a variety of other malignancies, including small cell lung cancer and tumors of the gastrointestinal system.

    Comment?

  17. Immuno-PET shows promise for detecting and treating pancreatic tumorsRead the original story w/Photo

    Jun 13, 2017 | PhysOrg Weblog

    ... research is offering hope. A first-in-human study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates the feasibility and safety of the novel human monoclonal antibody HuMab-5B1 with ...

    Comment?

  18. Personalised molecular therapy slows progression of tumorsRead the original story w/Photo

    Jun 13, 2017 | Newkerala.com

    ... on and longer survival. The study is scheduled to be presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

    Comment?

  19. Novel peptide receptor radionuclide therapy improves wellbeing of neuroendocrine cancer patientsRead the original story w/Photo

    Jun 13, 2017 | Medical News

    Malignant neuroendocrine tumors, commonly called NETs, are easy to miss and associated with discouraging survival rates and poor quality of life. A study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging shows how a novel peptide receptor radionuclide therapy is significantly improving patient wellbeing.

    Comment?

  20. Personalized PRRT improves radiation delivery to neuroendocrine tumorsRead the original story w/Photo

    Jun 12, 2017 | PhysOrg Weblog

    In personalized PRRT , injected activity of 177Lu-octreotate is adjusted to limit renal radiation dose and increase tumor radiation dose , as compared to empiric, fixed-injected activity PRRT. Credit: Michela Del Prete and colleagues, CHU de QuA bec - UniversitA Laval Neuroendocrine cancer is exceedingly difficult to manage and unlikely to be cured, but researchers intend to slow progression of these tumors and aid survival by personalizing patient dose of peptide-receptor radionuclide therapy , according to research presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging .

    Comment?